CSI Market
Sign In | Register

Coronado Biosciences Inc (CNDO) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CNDO Annual Cash Flow →
Cash flow data covering Coronado Biosciences Inc– offers a view into how Dec 31 2014's cash position has developed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2014)
12 Months
Operating Activities
Income-20.39
Depreciation & amortization0.02
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges0.72
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation5.55
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Income taxes0.00
Increase (Decrease) in Trading Securities-20.00
Accounts Receivable0.00
Accounts Payable-1.25
Increase (Decrease) in Interest Payable, Net-0.08
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.14
Other Working Capital-0.46
Other Noncash Expense0.63
Other net0.00
Payments for (Proceeds from) Other Operating Activities20.00
Discontinued operations0.00
Net Cash flow from Operating Activities-16.33
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Payments to Acquire Short-term Investments-0.35
Short-term Investments Acq.0.00
Real Estate Investments0.00
Increase (Decrease) in Restricted Cash-14.59
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Long-term Investments-2.93
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-5.42
Discontinued operations0.00
Net Cash Flow from Investing Activities-23.27
Financing Activities
Short-term debt Net14.01
Other borrowing transactions-0.01
Long-term debt - borrowings0.00
Long-term debt - repayments-13.65
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock4.09
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-14.59
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-10.16
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-16.33
Total Cash Flow-49.76
4 historic quarters locked

Sign in to unlock the full Coronado Biosciences Inc cash flow history.

Sign In Create Free Account

About Fortress Biotech Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001104659-26-095964

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Get the full CSIMarket dataset: Subscribe API License